These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29468055)

  • 1. Comparison of governance approaches for the control of antimicrobial resistance: Analysis of three European countries.
    Birgand G; Castro-Sánchez E; Hansen S; Gastmeier P; Lucet JC; Ferlie E; Holmes A; Ahmad R
    Antimicrob Resist Infect Control; 2018; 7():28. PubMed ID: 29468055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional health workforce monitoring as governance innovation: a German model to coordinate sectoral demand, skill mix and mobility.
    Kuhlmann E; Lauxen O; Larsen C
    Hum Resour Health; 2016 Nov; 14(1):71. PubMed ID: 27894307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leadership and governance in seven developed health systems.
    Smith PC; Anell A; Busse R; Crivelli L; Healy J; Lindahl AK; Westert G; Kene T
    Health Policy; 2012 Jun; 106(1):37-49. PubMed ID: 22265340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing national strategies on antimicrobial resistance in Thailand: potential challenges and solutions.
    Sommanustweechai A; Tangcharoensathien V; Malathum K; Sumpradit N; Kiatying-Angsulee N; Janejai N; Jaroenpoj S
    Public Health; 2018 Apr; 157():142-146. PubMed ID: 29524812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Socio-economic, governance and health indicators shaping antimicrobial resistance: an ecological analysis of 30 european countries.
    Maugeri A; Barchitta M; Puglisi F; Agodi A
    Global Health; 2023 Feb; 19(1):12. PubMed ID: 36829210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The global governance of antimicrobial resistance: a cross-country study of alignment between the global action plan and national action plans.
    Munkholm L; Rubin O
    Global Health; 2020 Nov; 16(1):109. PubMed ID: 33176810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare governance, professions and populism: Is there a relationship? An explorative comparison of five European countries.
    Pavolini E; Kuhlmann E; Agartan TI; Burau V; Mannion R; Speed E
    Health Policy; 2018 Oct; 122(10):1140-1148. PubMed ID: 30219372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Governing antimicrobial resistance: a narrative review of global governance mechanisms.
    Ruckert A; Fafard P; Hindmarch S; Morris A; Packer C; Patrick D; Weese S; Wilson K; Wong A; Labonté R
    J Public Health Policy; 2020 Dec; 41(4):515-528. PubMed ID: 32908184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges to effective governance in a low income healthcare system: a qualitative study of stakeholder perceptions in Malawi.
    Masefield SC; Msosa A; Grugel J
    BMC Health Serv Res; 2020 Dec; 20(1):1142. PubMed ID: 33317520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirations and realities of intergovernmental collaboration in national- level interventions: insights from maternal, neonatal and child health policy processes in Nigeria, 2009-2019.
    Etiaba E; Eboreime EA; Dalglish SL; Lehmann U
    BMJ Glob Health; 2023 Feb; 8(2):. PubMed ID: 36810159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pursuing the objectives of support to providers and external accountability through enabling controls - a study of governance models in Swedish primary care.
    Glenngård AH
    BMC Health Serv Res; 2019 Feb; 19(1):114. PubMed ID: 30744633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Institutional governance and responsiveness to antimicrobial resistance: a qualitative study of Australian hospital executives.
    Broom J; Broom A; Kenny K; Post JJ; Konecny P
    BMJ Open; 2021 Dec; 11(12):e055215. PubMed ID: 34862300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Child survival in England: Strengthening governance for health.
    Wolfe I; Mandeville K; Harrison K; Lingam R
    Health Policy; 2017 Nov; 121(11):1131-1138. PubMed ID: 29029812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unpacking multi-level governance of antimicrobial resistance policies: the case of Guangdong, China.
    Chan OSK; Wernli D; Liu P; Tun HM; Fukuda K; Lam W; Xiao Y; Zhou X; Grépin KA
    Health Policy Plan; 2022 Oct; 37(9):1148-1157. PubMed ID: 35775460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring the global response to antimicrobial resistance, 2020-21: a systematic governance analysis of 114 countries.
    Patel J; Harant A; Fernandes G; Mwamelo AJ; Hein W; Dekker D; Sridhar D
    Lancet Infect Dis; 2023 Jun; 23(6):706-718. PubMed ID: 36657475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten Years of Inaction on Antimicrobial Resistance: An Environmental Scan of Policies in Canada from 2008 to 2018.
    Van Katwyk SR; Grimshaw JM; Hoffman SJ
    Healthc Policy; 2020 May; 15(4):48-62. PubMed ID: 32538349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why we need multi-level health workforce governance: Case studies from nursing and medicine in Germany.
    Kuhlmann E; Larsen C
    Health Policy; 2015 Dec; 119(12):1636-44. PubMed ID: 26321192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The governance of antimicrobial resistance in Brazil: Challenges for developing and implementing a one health agenda.
    Corrêa JS; Zago LF; Da Silva-Brandão RR; de Oliveira SM; Fracolli LA; Padoveze MC; Cordoba G
    Glob Public Health; 2023 Jan; 18(1):2190381. PubMed ID: 36934430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Governance arrangements for health systems in low-income countries: an overview of systematic reviews.
    Herrera CA; Lewin S; Paulsen E; Ciapponi A; Opiyo N; Pantoja T; Rada G; Wiysonge CS; Bastías G; Garcia Marti S; Okwundu CI; Peñaloza B; Oxman AD
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011085. PubMed ID: 28895125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation research for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva infection prevention and control (IPC)-think tank (part 1).
    Zingg W; Storr J; Park BJ; Ahmad R; Tarrant C; Castro-Sanchez E; Tomczyk S; Kilpatrick C; Allegranzi B; Cardo D; Pittet D;
    Antimicrob Resist Infect Control; 2019; 8():87. PubMed ID: 31161034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.